Loading...
ROCO
6499
Market cap276mUSD
Nov 13, Last price  
98.80TWD
Name

Medeon Biodesign Inc

Chart & Performance

D1W1MN
ROCO:6499 chart
P/E
P/S
29.56
EPS
Div Yield, %
Shrs. gr., 5y
0.13%
Rev. gr., 5y
-8.39%
Revenues
293m
+49.19%
453,763,000123,056,00068,957,000298,317,000196,263,000292,808,000
Net income
-806m
L-33.13%
-261,985,000-192,735,0002,078,192,000-433,758,000-1,204,615,000-805,512,000
CFO
-833m
L+10.28%
-241,989,000-151,273,000-293,377,000-461,340,000-755,075,000-832,665,000
Dividend
Aug 23, 20230.49993 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in Taiwan and the United States. The company focuses on developing devices for minimally invasive surgeries, such as Duett, a vascular graft system; ClickClean, a solution to view throughout laparoscopic surgeries; AbClose to prevent port site herniation caused by improper closure; UroCross, an expander system; PUMA, a solution to treat orthopedic extremity injuries; and Cross-Seal, a large-bore closure device. It is involved in medical device contract manufacturing, equity investment and commerce of medical devices, manufacturing and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is headquartered in Taipei, Taiwan.
IPO date
Dec 11, 2014
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT